Scientific Sessions

 

Scientific Sessions

The schedule below reflects the invited program only.
The complete schedule, including the submitted program, will be available in late spring.

Plenary Sessions

10:30 - 11:15 a.m.

Association Welcome

Session: PL-01-01



11:15 - 11:45 a.m.

Biomarkers for the Diagnosis of Alzheimer’s Disease

Philip Scheltens, M.D., Ph.D.
Alzheimer Center, VU University Medical Center, Netherlands
Theme: Diagnosis and Prognosis
Session: PL-01-02


10:30 - 11 a.m.

Treating Alzheimer’s Disease by Targeting ß-Amyloid: Where Do We Stand?

Dennis Selkoe, M.D.
Harvard University, United States
Theme: Therapeutics
Session: PL-02-01


Park

11 - 11:30 a.m.

Fragile Minds: What Do Brain Biomarkers Tell Us about Risk for Alzheimer’s Disease?

Denise Park, Ph.D.
University of Texas, Dallas, United States
Theme: Diagnosis and Prognosis
Session: PL-02-02


Williams

10:30 - 11 a.m.

Genetics of Alzheimer's Disease

Julie Williams, Ph.D.
Cardiff University, United Kingdom
Theme: Basic and Translational Science
Session: PL-03-01


Lovestone

11 - 11:30 a.m.

The Future of Electronic Health Records and Big Data in Dementia Research

Simon Lovestone, Ph.D.
University of Oxford, United Kingdom
Theme: Public Health and Psychosocial
Session: PL-03-02


10:30 - 11 a.m.

Inge Grundke-Iqbal Award for Alzheimer’s Research: Novel Allele-dependent Role for APOE in Controlling the Rate of Synapse Pruning by Astrocytes

Won-Suk Chung, Ph.D.

Theme: Basic and Translational Science
Session:PL-04-01


11 - 11:30 a.m.

Neurotoxicity of Tau

Virginia Man-Yee Lee, Ph.D.
University of Pennsylvania, United States
Theme: Therapeutics
Session: PL-04-02


10:30 - 11 a.m.

Cellular Mechanisms of Frontotemporal Lobar Degeneration (FTLD)

Aaron Gitler, Ph.D.
Stanford University, United States
Theme: Basic and Translational Science
Session: PL-05-01


11 - 11:30 a.m.

Neuropathology as a Tool to Propel Public Health Research in Dementia

Julie Schneider, M.D.
Rush Alzheimer’s Disease Center, United States
Theme: Public Health and Psychosocial
Session: PL-05-02



Symposium Sessions

Sunday, July 16
  • 8 - 9:30 a.m.
    Alzheimer’s Disease In Extreme Ages: Oldest Old And in Young Adults, A Public Health Perspective
    Theme: Public Health and Psychosocial
    Session S1-01

    Chair: Mary Ganguli, University of Pittsburg School of Medicine, United States

PRESENTATIONS

SPEAKERS


Amyloid and Tau Deposition Across Ages

Gil Rabinovici
University of California,
San Francisco, United States


Prevalence and Incidence of Early Onset and Late Onset Dementia

Maria Glymour
University of California,
San Francisco, United States


Alzheimer Disease at the Extremes of Ages: Clinical Epidemiology, Diagnosis and Care

Chiadi Onyike
John’s Hopkins University,
United States


Increased Longevity: Impact on Public Health and Brain Aging

Claudia Kawas
University of California, Irvine,
United States


Sunday, July 16
  • 8 - 9:30 a.m.
    CTE and Relationship of Trauma to Dementia
    Theme: Basic and Translational Science
    Session S1-02

    Chairs: Matthew Frosch, Massachusetts General Hospital/Harvard Medical School, United States, and Delphine Boche, University of Southampton, United Kingdom

PRESENTATIONS

SPEAKERS


Tau Pathology and Traumatic Encephalopathy

Ann McKee
Boston University School of Medicine,
United States


Dementia Resulting from Traumatic Brain Injury

Daniel Perl
Center for Neuroscience and Regenerative Medicine Brain Tissue Repository (CNRM), United States


Linking Traumatic Brain Injury to Neurodegenerative Disease

Steve Gentleman
Imperial College London,
United Kingdom


Neurodegenerative Pathobiology in Preclinical Models of Repetitive Mild Traumatic Brain Injury

Fiona Crawford
Roskamp Institute,
United States


Monday, July 17
  • 8 - 9:30 a.m.
    Relationship Between Tau and Amyloid Imaging Biomarkers
    Theme: Diagnosis and Prognosis
    Session: S2-01

    Chairs: Susan Landau, University of California Berkeley, United States, and Agneta Nordberg, Karolinska University Hospital Huddinge, Sweden

PRESENTATIONS

SPEAKERS


Imaging Amyloid and Tau Pathology: Lessons Learned

Keith Johnson
Massachusetts General Hospital,
United States


Comparison of Different Tau PET Tracers and Their Relationship to Amyloid

Christopher Rowe
Austin Health,
Australia


Time Course of Amyloid and Tau Deposition in Autosomal Dominant Alzheimer’s Disease

Tammie Benzinger
Washington University in St. Louis School of Medicine, United States; Knight Alzheimer Disease Research Center, United States


In Vivo Cortical Spreading of Tau and Amyloid

Hannah Cho
Gangnam Severance Hospital, Yonsei University College of Medicine, Korea, Republic of (South)


Monday, July 17
  • 8 - 9:30 a.m.
    Cognitive Training as an Intervention for MCI and Dementia
    Theme: Therapeutics
    Session: S2-02

    Chair: Sylvie Belleville, Universit é de Montréal, Canada

PRESENTATIONS

SPEAKERS


Commercially Available Computerized Cognitive Training and Cognoition

Glenn Smith
University of Florida,
United States


Cognitive Training and MCI

Feng Lin
University of Rochester,
United States


Brain Changes and Cognitive Training

Etienne de Villers-Sidani
Montreal Neurological Institute,
Canada


The Promise and Perils of Cognitive Training for Promoting Late-Life Cognitive Health

Elizabeth Stine-Morrow
The Adult Learning Lab, Beckman Institute,
United States


Tuesday, July 18
  • 8 - 9:30 a.m.
    Pathologic Heterogeneity of Alzheimer’s Disease
    Theme: Diagnosis and Prognosis
    Session: S3-01

    Chairs: Liana Apostolova, Indiana University School of Medicine, United States, and Kejal Kantarci, Mayo Clinic, United States

PRESENTATIONS

SPEAKERS


Mixed Pathology in Alzheimer’s Disease

Glenda Halliday
The University of Sydney,
Australia


Neuropathological Heterogeneity in Familial and Late-onset Alzheimer’s Disease

Nigel Cairns
Washington University School of Medicine,
United States


Atypical Alzheimer’s Disease Pathology

Melissa Murray
Mayo Clinic,
United States


Imaging Biomarkers of Pathologic Heterogeneity

Bradford Dickerson
Massachusetts General Hospital/Harvard Medical School,
United States


Tuesday, July 18
  • 8 - 9:30 a.m.
    Prion-Like Propagation as Potential Mechanism for Neurodegenerative Disease
    Theme: Therapeutics
    Session: S3-02

    Chair: Eric Karran, AbbVie, United States

PRESENTATIONS

SPEAKERS


Prion-like Properties of Tau

Marc Diamond
University of Texas Southwestern Medical Center,
United States


Tau Spreading In Vivo

Florence Clavaguera
University of Basel,
Switzerland


The Prion-like Properties of Amyloid-β

Mathias Jucker
Hertie Institute for Clinical Brain Research,
University of Tuebingen, Germany


Spreading of Pathology in Parkinson’s Disease

Jeffrey Kordower
Rush University,
United States


Wednesday, July 19
  • 8 - 9:30 a.m.
    Music, Cognition and Dementia: Evidence and Implications
    Theme: Public Health and Psychosocial
    Session: S4-01

    Chair: Pieter Jelle Visser, VU University Medical Center, Netherlands

PRESENTATIONS

SPEAKERS


Music and Underlying Brain Function in Persons with Dementia

Jason Warren
University College London,
United Kingdom


Music Interventions and Cognitive Aging

Julene Johnson
University of California,
San Francisco, United States


Efficacy of Musical Interventions in Dementia: Methodological Requirements

Séverine Samson
Univ Lille Nord de France,
France


Cognitive, Emotional and Social Benefits of Regular Musical Activities in Early Dementia

Teppo Särkämö
Cognitive Brain Research Unite (CBRU),
University of Helsinki, Finland


Thursday, July 20
  • 8:30 - 10 a.m.
    RAN Translation/Dipeptide Aggregates in Multiple Diseases
    Theme: Basic and Translational Science
    Session: S5-01

    Chair: Christine Van Broeckhoven, Neurodegenerative Brain Diseases Group, VIB, Belgium

PRESENTATIONS

SPEAKERS


c9RAN Proteins As a Hallmark for C9orf72-Linked FTD and ALS (c9FTD/ALS)

Leonard Petrucelli
Mayo Clinic,
United States


Targeting G4C2 G-Quadruplexes in C9orf72 FTD/ALS

Adrian Isaacs
University College London Institute of Neurology,
United Kingdom


C9orf72 Translation and Disease

Dieter Edbauer
German Center for Neurodegenerative Diseases (DZNE),
Germany


Exploiting RAN Translation-Specific Mechanisms as a Therapeutic Approach Across Multiple Neurodegenerative Diseases

Peter Todd
University of Michigan Medical School, United States; VA Medical Center,
United States




Join ISTAART

ISTAART members receive discounted registration rates and can access exclusive events at AAIC. Join today to receive these exclusive member benefits.

join today

Educational Workshops

Learn the basics or brush up on your skills by attending an AAIC educational workshop. Topics include: clinical trials, fluid biomarkers, neuroimaging and neuropathology.

Learn More

LONDON CALLING

July 16 – 20: Annual Conference
July 14 – 15: Preconferences
July 16 – 19: Exhibit Dates
London, England

Join Us for AAIC 2017

Cobblestone streets, fish and chips and entertainment old and new await you!

Register Now

Join the Conversation #AAIC17

Follow

Exhibitors

Exhibitors

Sponsors

Sponsorship

> 1200px
lg
> 992px
md
> 768px
sm
< 767px
xs